http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018504595-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96425 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2016-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2018504595-A |
| titleOfInvention | Prostate cancer marker and use thereof |
| abstract | The present invention relates to compositions and methods for diagnosing, searching and treating cancer, including but not limited to cancer markers. In particular, the present invention relates to LRG1 protein markers for use in diagnosis, prognosis, and determination in the treatment of prostate cancer. |
| priorityDate | 2015-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 159.